Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04317053 · ClinicalTrials.gov registry record · NA
Multi-Center Randomized Controlled Trial of Relay- NYC's Nonfatal Overdose Response Program
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 253
- Enrollment target
NCT04317053 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 253 participants.
The verdict
NCT04317053, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 253 participants
- Enrollment target
Study Summary
The New York City (NYC) Department of Health and Mental Hygiene (DOHMH) has implemented Relay, a novel program that engages and intervenes with individuals in the ED following an opioid OD and for the next 90 days, with the goal of preventing subsequent OD events. The proposed randomized controlled trial will evaluate the impact of Relay on preventing subsequent opioid-related adverse events. A total of 350 eligible individuals with nonfatal opioid OD presenting to one of four participating EDs will be enrolled and randomized to one of two arms: 1) site-directed care (SDC) or 2) Relay-peer-delivered OD education and treatment linkage, including 90 days of peer navigation. Outcomes will be measured for 12 months through interviews and administrative health data.
Interventions
- BEHAVIORAL RELAY
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 253 participants |
| Start Date | 2020-10-08 |
| Est. Completion | 2023-07-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04317053
The ClinicalTrials.gov registry entry for NCT04317053 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 253 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which RELAY is the first listed.
NCT04317053 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04317053 about?
NCT04317053 is a clinical study titled "Multi-Center Randomized Controlled Trial of Relay- NYC's Nonfatal Overdose Response Program". The New York City (NYC) Department of Health and Mental Hygiene (DOHMH) has implemented Relay, a novel program that engages and intervenes with individuals in the ED following an opioid OD and for the next 90 days, with the goal of preventing subsequent OD events. The proposed randomized controlled ...
What is the current status of trial NCT04317053?
This trial is currently completed. It is a NA study. The enrollment target is 253 participants. The study started on 2020-10-08. Estimated completion is 2023-07-01.
What interventions are being tested in trial NCT04317053?
The interventions under investigation include: RELAY (BEHAVIORAL).
Who is sponsoring clinical trial NCT04317053?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.